Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
See Latest ArticlesIs tight glycemic control in type 2 diabetes really worthwhile?: YES
Canadian Family Physician, 06/15/09
Clement M et al. - Since the first big landmark trial on glycemic control and complications in type 1 diabetes (DCCT [Diabetes Control and Complications Trial]) was published in 1993, almost every major trial for type 1 and type 2 diabetes has consistently demonstrated the beneficial effects of lowering glucose on diabetes complications.
- Diabetes trials have consistently shown that lower hemoglobin A1c levels decrease complications of the disease.
- Longer trials, such as the DCCT and the EDIC follow-up, the UKPDS, and the Steno-2 Study, have demonstrated the additional macrovascular benefits of tight glycemic control.
- The "legacy" effect of tight control at an earlier stage of disease has a lasting influence on the reduction of both microvascular and macrovascular complications.
- The ACCORD trial findings should not be generalized to younger, healthier patients.
Today in General Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Liver disease: Early signs you may be missing
APCToday, 10/21/09
Beyond office sphygmomanometry: Ways to better assess blood pressure
Cleveland Clinic Journal of Medicine, 11/03/09
Vitamin D: An Evidence-Based Review
Journal of the American Board of Family Medicine, 11/09/09
Sponsor
Article Search
Sponsor
Sponsor